INTRODUCTION
Most of the family members of β-phenethylamides constitute an important part of the natural and synthetic products discover so far. 1 The biological importance of these small molecules (SM) is based on their selectivity to induced apoptosis in different malignant cell lines, including melanoma and leukemia. 2 Due to the value of these amides in cancer research and the difficult to extract their analogues from natural sources, i.e. Isodon excisus. 3 The responsibility to develop a novel synthetic protocols that allow the preparation of new libraries of β-phenethylcinnamamides lies on organic chemistry (Scheme 1).
Scheme 1. Synthetic and natural sources of phenethylcinnamamides
According to the aspects described above and our current interests in N-phenethylcinnamamides, we designed a strategy for the preparation of these compounds under the parameters of green chemistry and improving some synthetic aspects.
RESULTS AND DISCUSSION
Our synthetic plan required a series of β-phenylethylamines 3a-d that were prepared through the reduction of the corresponding β-nitrostyrenes 2a-d. 4 These nitroalkanes were prepared in excellent yield from the respective aldehydes 1a-d using ethanolamine supported on SiO 2 (ETAM/SiO 2 ) as a catalyst 5 (Scheme 2).
Scheme 2. Preparation of β-phenylethylamines 3a-d.
In the final stage, each β-phenylethylamine was mixed with boric acid (10 % mol) and trans-cinnamic acid 4a-b in toluene at 110 ºC leading the desired amides 5a-h in good to excellent yields 6 (Scheme 3).
Scheme 3. Synthesis of new β-phenethylcinnamamides.
All products 5a-h ( Reducing the β-nitrostyrenes in toluene lead the complete conversion (TLC) into the desired amine and allow it's used in the final step without further purification, facilitating their handling and integrity.
CONCLUSION
We have developed an efficient and easy protocol for the synthesis of β-phenethylcinnamamides, from available commercial reagentes, under green and mild conditions. The obtained compounds could serve for a SM screening in different biological systems.
